AI for Drug Discovery, Biomarker Development and
Advanced R&D Landscape Overview 2020
Investment Digest

This Investment Digest is summarizing key players and observations in the private equity and venture capital ecosystem, focusing on the pharmaceutical Artificial Intelligence (AI).

 

Here we have presented the information about key industry trends, 240 promising AI-driven biotech startups, and 50 leading biotech investors in this sector, outlining major investment rounds and relevant R&D partnerships illustrating the industry traction and readiness of institutional investors (big pharma/biotech) to potentially acquire most successful AI-vendors.